ARES ACQUISITION CORP-A (AAC) Stock Fundamental Analysis

NYSE:AAC • KYG330321061

10.79 USD
+0.02 (+0.19%)
Last: Nov 6, 2023, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall AAC gets a fundamental rating of 1 out of 10. We evaluated AAC against 0 industry peers in the Unkown industry. AAC has a bad profitability rating. Also its financial health evaluation is rather negative. AAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • AAC had negative earnings in the past year.
  • AAC had a negative operating cash flow in the past year.
AAC Yearly Net Income VS EBIT VS OCF VS FCFAAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2020 2021 2022 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -1.32%
ROE -1.59%
ROIC N/A
ROA(3y)0.34%
ROA(5y)N/A
ROE(3y)-40.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAC Yearly ROA, ROE, ROICAAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2020 2021 2022 0 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAC Yearly Profit, Operating, Gross MarginsAAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2020 2021 2022 0 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, AAC has about the same amount of shares outstanding.
  • The debt/assets ratio for AAC is higher compared to a year ago.
AAC Yearly Shares OutstandingAAC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2020 2021 2022 20M 40M 60M 80M 100M
AAC Yearly Total Debt VS Total AssetsAAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 5.22 indicates that AAC is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.01 indicates that AAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 5.22
ROIC/WACCN/A
WACCN/A
AAC Yearly LT Debt VS Equity VS FCFAAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2020 2021 2022 0 200M 400M 600M 800M

2.3 Liquidity

  • AAC has a Current Ratio of 0.01. This is a bad value and indicates that AAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AAC has a Quick Ratio of 0.01. This is a bad value and indicates that AAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
AAC Yearly Current Assets VS Current LiabilitesAAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2020 2021 2022 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for AAC have decreased strongly by -173.41% in the last year.
EPS 1Y (TTM)-173.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAC Yearly Revenue VS EstimatesAAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 100M 200M 300M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • AAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAC Price Earnings VS Forward Price EarningsAAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAC Per share dataAAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ARES ACQUISITION CORP-A

NYSE:AAC (11/6/2023, 8:04:00 PM)

10.79

+0.02 (+0.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14
Earnings (Next)02-27
Inst Owners5.09%
Inst Owner Change0%
Ins Owners14.47%
Ins Owner Change0%
Market Cap761.77M
Revenue(TTM)N/A
Net Income(TTM)-6.42M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS5.71
TBVpS5.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.32%
ROE -1.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.34%
ROA(5y)N/A
ROE(3y)-40.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 5.22
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-139.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.45%
OCF growth 3YN/A
OCF growth 5YN/A

ARES ACQUISITION CORP-A / AAC FAQ

What is the ChartMill fundamental rating of ARES ACQUISITION CORP-A (AAC) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AAC.


What is the valuation status of ARES ACQUISITION CORP-A (AAC) stock?

ChartMill assigns a valuation rating of 0 / 10 to ARES ACQUISITION CORP-A (AAC). This can be considered as Overvalued.


Can you provide the profitability details for ARES ACQUISITION CORP-A?

ARES ACQUISITION CORP-A (AAC) has a profitability rating of 0 / 10.


Can you provide the financial health for AAC stock?

The financial health rating of ARES ACQUISITION CORP-A (AAC) is 2 / 10.